HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
94
|
101 |
GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
79
|
13 |
FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
74
|
50 |
SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
74
|
8 |
CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
69
|
53 |
FTO |
Q9C0B1
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
8.4E-08 |
0.486 |
0.885 |
64
|
61 |
FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
53
|
30 |
CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
52
|
70 |
TCF7L2 |
Q9NQB0
|
transcription factor 7 like 2
|
|
1.00 |
0.485 |
0.846 |
50
|
31 |
JAZF1 |
Q86VZ6
|
JAZF zinc finger 1
|
|
0.90 |
0.582 |
0.654 |
49
|
45 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
48
|
44 |
RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
46
|
41 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
44
|
49 |
BACH2 |
Q9BYV9
|
BTB domain and CNC homolog 2
|
|
1.00 |
0.539 |
0.731 |
41
|
29 |
IRF1-AS1 |
Q8N8D9
|
IRF1 antisense RNA 1
|
|
4.2E-03 |
0.670 |
0.385 |
41
|
26 |
TMEM258 |
P61165
|
transmembrane protein 258
|
|
1.9E-03 |
0.644 |
0.654 |
40
|
13 |
ZMIZ1 |
Q9ULJ6
|
zinc finger MIZ-type containing 1
|
|
1.00 |
0.588 |
0.615 |
40
|
33 |
APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
38
|
13 |
DLEU1 |
O43261
|
deleted in lymphocytic leukemia 1
|
|
0.47 |
0.569 |
0.692 |
38
|
64 |
MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
38
|
56 |
MYRF |
Q9Y2G1
|
myelin regulatory factor
|
|
1.00 |
0.584 |
0.731 |
37
|
13 |
ZPR1 |
O75312
|
ZPR1 zinc finger
|
|
8.9E-09 |
0.674 |
0.462 |
36
|
16 |
JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
35
|
48 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
35
|
41 |